Gewurz Benjamin E

31PUBLICATIONS
104CO-AUTHORS
Innate immunityHaematological tumoursPredictive and prognostic markersMolecular targetsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 13, 2026
A tonsil organoid model reveals Epstein-Barr virus-infected germinal center B cell states during primary infection.

|Jun 15, 2026
Arginine metabolism supports de novo pyrimidine biosynthesis to block DNA damage and maintain Epstein-Barr virus latency.

|May 14, 2026
EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers.

|Apr 10, 2026
CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.

Eric M Burton, Yifei Liao, Davide Maestri

|Feb 10, 2026
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer.

Sarah Preston-Alp, Yin Wang, Matteo Bergonzoni

|Jan 26, 2026
Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway.

Yizhe Sun, Shunji Li, Bidisha Mitra

Pageof 6

Frequent Collaborators

6 joint publications

Mingxiang Teng

6 joint publications

Bo Zhao

6 joint publications

Rui Guo

4 joint publications

Yifei Liao